{
    "title": "114_hr3284",
    "content": "The Act titled \"Mary Jo Lawyer Spano Mesothelioma Patient Registry Act of 2015\" establishes a patient registry for mesothelioma data collection and research under Title III of the Public Health Service Act. The Secretary will develop a patient registry to collect data on mesothelioma in the US, to track the epidemiology of patients and report on their health information. The patient registry will track mesothelioma patients, collect health information, report treatment outcomes, describe incidence and prevalence in the US, facilitate research, and examine environmental factors. The patient registry aims to describe the incidence and prevalence of mesothelioma in the US, facilitate research, examine environmental and occupational factors associated with the disease, outline key demographic factors, and make non-identifiable information available to the public for research, prevention, and treatment purposes. The patient registry collects information on mesothelioma incidence and prevalence in the US, including other relevant data when possible, to facilitate research and make non-identifiable information available for research, prevention, and treatment purposes. The patient registry collects information on mesothelioma in the US, including demographics, risk factors, and other relevant data for research and treatment purposes. The patient registry for mesothelioma collects information on demographics, risk factors, diagnosis markers, and disease progression. It also includes data on the epidemiology, natural history, and prevention of the disease. The Secretary shall consult with experts on mesothelioma epidemiology, natural history, prevention, detection, management, treatment, and outcomes measures, including non-Federal epidemiologists. The Secretary shall consult with individuals with expertise in mesothelioma, including epidemiologists, representatives of national associations, health information technology experts, clinicians, and research scientists. The Secretary shall consult with individuals with expertise in mesothelioma, including epidemiologists, health information technology experts, clinicians, and research scientists with experience in translational research or utilizing surveillance systems for scientific research purposes. Coordination with other Federal agencies will involve sharing information and analysis with departments like the National Institutes of Health, the Food and Drug Administration, and the Centers for Medicare & Medicaid Services. The Secretary will share information from the registry with Federal departments and agencies like the National Institutes of Health, FDA, and CMS. Information from the registry will also be made available to the public, including researchers, with privacy protections in place. The Secretary will ensure that information from the registry is shared with the public and researchers, with stringent privacy protections in place. Additionally, reports will be submitted to Congress within 18 months of the enactment of the Mary Jo Lawyer Spano Mesothelioma Patient Registry Act of 2015. The Secretary will submit a report to Congress within 18 months of the enactment of the Mary Jo Lawyer Spano Mesothelioma Patient Registry Act of 2015, outlining findings, future plans for the registry, and activities undertaken to establish partnerships. The Secretary will submit a report to Congress within 4 years of the enactment of the Mary Jo Lawyer Spano Mesothelioma Patient Registry Act of 2015, detailing the implementation of the registry, including partnerships with research and patient advocacy communities. The Secretary will submit a report to Congress on the implementation of the mesothelioma patient registry, detailing the development, information collected, use, and coordination of databases. The Secretary will report to Congress on the mesothelioma patient registry, including information on development, use, and coordination of databases."
}